样式: 排序: IF: - GO 导出 标记为已读
-
Untwisting healthcare access disparities: A comprehensive analysis of demographic, socio-economic and racial disparities impacting patient outcomes in myocardial infarction patients Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-17 Aayushi Sinha, Manisha Lakhanpal, Mboudou Michel Salomon, Sarvinoz Albalushi, Sai Akhil Veeramachaneni, Padmapriya Muthu
Myocardial infarction (MI) is one of the most life-threatening pathologies characterized by sudden cardiac death and is among the leading causes of mortality in the developed world. This study investigates the demographic, socio-economic, and healthcare access disparities in the US among patients with myocardial infarction (MI). This was a retrospective original research study conducted using the BRFSS
-
SEX DIFFERENCES IN HEART TRANSPLANTATION - ANALYSIS OF THE NATIONAL INPATIENT SAMPLE 2012-2019 Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-17 Nakeya Dewaswala MD, Huzefa Bhopalwala MD, Abdul Mannan Khan Minhas MD, Khadija Amanullah MD, Dmitry Abramov MD, Samiullah Arshad MD, Sourbha Dani MD, Gaurang Vaidya MD, Dipanjan Banerjee MD, Emma Birks MD, Erin Michos MD
[Display omitted]
-
The impact of Frailty as a critical mediator causing postoperative neurocognitive disorders in postoperative cardiac patients. Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-16 Hu Li MD, Jinfeng Li MD, Xin Huang MD, Bhushan Sandeep PhD, Jing Yang MD
Frailty is prevalent in elderly cardiac patients and may be a critical predictor of post-operative neurocognitive disorders (PND). The aim of this review was to demonstrate the correlation of frailty with PND in postsurgical elder patients. A review of published literature and bibliometric analysis was undertaken. Electronic databases from 2009 to 2022 were searched to identify articles that evaluated
-
Unraveling Disparities: Probing Gender, Race, and Geographic Inequities in Pulmonary Heart Disease Mortality in the United States: An Extensive Longitudinal Examination (1999-2020) Leveraging CDC WONDER Data Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-16 Waqar Arif MBBS, Riteeka Kumari Bhimani MBBS, Mohsin Ali shah MBBS, Zainab tausif MBBS, Umer Nisar MBBS, Rohet kumar MBBS, Parshant Dileep Bhimani MBBS, Syed Shoaibullah MBBS, Muhammad Abdullah Naveed MBBS, Adarsh Raja MBBS, Sandesh Raja MBBS, Fnu Deepak MBBS, Muhammad Ashir Shafique MBBS, Muhammmad Saqlain Mustafa MBBS
This comprehensive study delves into the epidemiological landscape of Pulmonary Heart Disease (PHD) mortality in the United States from 1999 to 2020, leveraging the extensive CDC WONDER database. PHD encompasses conditions affecting the right side of the heart due to lung disorders or elevated pressure in the pulmonary arteries, including pulmonary hypertension, pulmonary embolism, and chronic thromboembolic
-
A review regarding the article ‘The cardioprotective potential of sodium-glucose cotransporter 2-inhibitors in breast cancer therapy-related cardiac dysfunction – A systematic review’ Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-16 Gang Zhao MBBS, Lei Wang MBBS, Hong Fang MBBS, Liwei Wang MD
Breast cancer is one of the most common types of cancer, representing 15% of all new cancer cases in the United States. Approximately 12.4% of all women will be diagnosed with breast cancer during their lifetime. In the past decades, a decrease in cancer-related mortality is evident as a result of early screening and improved therapeutic options. Nonetheless, breast cancer survivors face long-term
-
Targeting Inflammatory Signaling Pathways with SGLT2 Inhibitors: Insights into Cardiovascular Health and Cardiac Cell Improvement Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-16 Fatmah R. Alsereidi, Zenith Khashim, Hezlin Marzook, Anamika Gupta, Ahmed M. Shaaban, Mahmoud M. Ramadan, Mohamed A. Saleh
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have attracted significant attention for their broader therapeutic impact beyond simply controlling blood sugar levels, particularly in their ability to influence inflammatory pathways. This review delves into the anti-inflammatory properties of SGLT2 inhibitors, with a specific focus on canagliflozin, empagliflozin, and dapagliflozin. One of the key
-
Comment on: “Sex differences in patients presenting with acute coronary syndrome: a state-of-the-art review” Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-16 John E. Madias MD FACC FAHA
-
A Multidisciplinary Approach of a Patient with Pheochromocytoma Presenting as Recurrent Acute Fulminant Myocarditis: A Rare Case Report and Comprehensive Review of Literature Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-16 Januar Wibawa Martha, Hawani Sasmaya Prameswari, Fatihatul Firdaus Munita, Nuraini Yasmin Kusumawardhani, Melawati Hasan, Astri Astuti, Nanny Natalia Mulyani, Hasrayati Agustina, Minsy Titi Sari
Fulminant myocarditis (FM) is a rare illness characterized by abrupt and severe widespread cardiac inflammation, which frequently results in mortality due to cardiogenic shock, ventricular arrhythmias, or multiorgan system failure. Pheochromocytoma is an uncommon and difficult-to-diagnose cause of FM, and it is associated with a significant risk of recurrent acute myocarditis. There is, however, little
-
Comment on “Inclisiran siRNA technology in the management of dyslipidemia: A narrative review of clinical trials” Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-16 Hussain Sohail Rangwala, Hareer Fatima, Faiza Riaz, Burhanuddin Sohail Rangwala
The study "Inclisiran siRNA technology in the management of dyslipidemia: A narrative review of clinical trials" evaluates inclisiran's efficacy and safety in reducing LDL cholesterol levels across diverse patient populations. Twelve clinical trials were reviewed, demonstrating consistent LDL-C reduction, even in statin intolerance or resistance cases, with sustained efficacy observed over various
-
Association between serum beclin 1 level and cardiac valvular calcification in hemodialysis patients Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-16 Hayam Ahmed Hebah, Hadeer Moamen Kamel, Islam Mahmoud Bastawy, Fatma Abdelrahman Ahmed
Cardiovascular calcification is a pervasive issue throughout chronic kidney disease (CKD) progression. Autophagy, a fundamental cellular process, exerts significant influence on various cardiac pathologies, including arrhythmias, atherosclerosis, heart failure, and notably, valvular, and vascular calcifications. Beclin-1, a crucial eukaryotic protein, plays a major regulatory role in autophagy as part
-
Influence of age and sex on the thickness of the radial artery wall Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-15 Misbaou Barry MDPhD, Fatoumata Barry MD, Mesut Gun, Paul Padurean MD, Jean Fortuné Ikoli MD, Eric Havet MDPhD, Bessem Gara Ali MD, Thierry Caus MDPhD
The aim of this study is to investigate whether there is a relationship between age or sex and the thickness of the radial artery wall. We harvested human radial arteries from 48 cadavers (30 men and 18 women) in the anatomy laboratory. Histological sections of 3μm thickness were prepared at the Laboratory of Anatomy and Pathological Cytology, mounted on slides, and stained with hematoxylin-phloxine-safran
-
Comment on: Long-Term Outcome and Predictor of Mortality in Patient with Pulmonary Embolism Undergoing Catheter-Directed Thrombolysis: A 10-Year Retrospective Study. Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-14 Muhammad Aniq Amir, Muhammad Abrar Amir, Aashish Kumar, Syed Ali Arsal
-
Comment on, “Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): A systematic review and meta-analysis” Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-14 Paschalis Karakasis
-
A review regarding the article ‘Supervised exercise training in heart failure with preserved ejection fraction: A systematic review and meta-analysis of randomized controlled trials.’ Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-14 Ping Zhang MD, Yunfei Ling PhD
Heart failure is a clinical syndrome with different etiologies and phenotypes. For all forms, supervised exercise training and individual physical activity are class IA recommendations in current guidelines. Over the past two decades it has become recognized that physical deconditioning may play a key role in the progression of symptoms and poor outcomes. A number of prior studies have assessed the
-
THE DIFFERENTIATION OF THE COMPETITIVE ATHLETE WITH PHYSIOLOGIC CARDIAC REMODELING FROM THE ATHLETE WITH CARDIOMYOPATHY Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-05 R, O, B, E, R, T, , J, ., , H, E, N, N, I, N, G, , M, ., D, ., , F, A, C, P, , F, C, C, P, , F, A, C, C, , F, A, H, A
There are currently 5 million active high school, collegiate, professional, and master athletes in the United States. Regular intense exercise by these athletes can promote structural, electrical and functional remodeling of the heart, which is termed the “athlete's heart.” In addition, regular intense exercise can lead to pathological adaptions that promote or worsen cardiac disease. Many of the athletes
-
Untwisting healthcare access disparities: A comprehensive analysis of demographic, socio-economic and racial disparities impacting patient outcomes in myocardial infarction patients. Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-04 Aayushi Sinha, Manisha Lakhanpal, Mboudou Michel Salomon, Sarvinoz Albalushi, Sai Akhil Veeramachaneni, Padmapriya Muthu
Myocardial infarction (MI) is one of the most life-threatening pathologies characterized by sudden cardiac death and is among the leading causes of mortality in the developed world. This study investigates the demographic, socio-economic, and healthcare access disparities in the US among patients with myocardial infarction (MI). This was a retrospective original research study conducted using the BRFSS
-
Critique on: “Dose-response associations of dietary inflammatory potential with health outcomes: a prospective cohort study of 198,265 UK biobank participants” Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-02 M. Anas Faheem MBBS, Bazil Azeem MBBS, Ayesha Khan MBBS
-
Complications in transcatheter aortic valve replacement: A comprehensive analysis and management strategies Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-02 Qi Zou, Zhiliang Wei, Shougang Sun
Transcatheter Aortic Valve Replacement (TAVR) marks a significant advancement in treating aortic stenosis (AS), especially for patients with high surgical risks. This concise review outlines TAVR's development, its broader application to include lower-risk patients, and innovations in the device and procedural technology. Clinical trials, notably the PARTNER series, affirm TAVR's efficacy, showing
-
Long-term impact of mediterranean diet on cardiovascular disease prevention: A systematic review and meta-analysis of randomized controlled trials Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-03-01 Sneha Annie Sebastian MD, Inderbir Padda MD MPH, Gurpreet Johal MD FACC FASN FRCPC
Dietary modification plays a pivotal role in the prevention of cardiovascular disease (CVD), with particular emphasis on the potential benefits associated with adopting a Mediterranean diet (MedDiet). Numerous observational studies have explored the impact of the MedDiet on CVD prevention, addressing both primary and secondary prevention. However, a substantial portion of the primary evidence comes
-
Letter to editor: The relationship between vitamin D status and cardiovascular diseases Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-29 Asma Riaz, Sidra Kalsoom, Muhammad Hamza, Sara Asif
-
Letter to the editor of current problems in cardiology Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-29 Vladislav Zlatkin iBSc (Hons), Tristan J Barber MA MD FRCP
-
Commented on: “Attendance-related healthcare resource utilisation and costs in patients with Brugada syndrome in Hong Kong: A retrospective cohort study” Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-29 Aiman Soomro MBBS, Rakhshan Zulfiqar MBBS
-
Comment on “Evaluation of brain function in adult patent ductus arteriosus surgery: A multimodal monitoring approach” by “Qin X, et al. Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-29 Rabia Asim MBBS, Bazil Azeem MBBS, Mata-e-Alla Dogar MBBS
-
Comment on: Severe pulmonary hypertension in pulmonary alveolar microlithiasis: A comprehensive literature review Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-29 Burhanuddin Sohail Rangwala, Hussain Sohail Rangwala
This letter commends the study "Severe pulmonary hypertension in pulmonary alveolar microlithiasis: A comprehensive literature review" for its thorough exploration of Pulmonary Alveolar Microlithiasis (PAM) and its association with pulmonary hypertension (PH). The study offers insights into PAM's genetics, clinical manifestations, diagnostic approaches, and treatment modalities. It highlights the importance
-
Comment on, “Systematic literature review and critical analysis of RDW in patients with aortic pathologies” Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-29 Hussain Sohail Rangwala, Hareer Fatima, Burhanuddin Sohail Rangwala
Recent medical research has explored Red Cell Distribution Width (RDW) as a potential biomarker for predicting adverse clinical outcomes in patients with aortic pathologies. The study "Systematic literature review and critical analysis of RDW in patients with aortic pathologies" conducted a pooled analysis of 704 patients, revealing a consistent association between elevated RDW levels and adverse clinical
-
Tirzepatide: A novel cardiovascular protective agent in type 2 diabetes mellitus and obesity Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-28 Muhammad Bilal Sardar, Zain Ali Nadeem, Muhammad Babar
Cardiovascular disease (CVD) remains a major global health concern, and obesity and diabetes mellitus have been found to be important risk factors. Tirzepatide a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP1) receptor agonist has been shown to have cardioprotective effects. Noteworthy benefits of Tirzepatide include decreased cardiovascular risk factors in
-
Sex differences in patients presenting with acute coronary syndrome: a state-of-the-art review Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-28 Filippo Zilio, Francesca Musella, Laura Ceriello, Giuseppe Ciliberti, Daniela Pavan, Maria Teresa Manes, Adelina Selimi, Pietro Scicchitano, Gianmarco Iannopollo, Stefano Albani, Federico Fortuni, Massimo Grimaldi, Furio Colivicchi, Fabrizio Oliva
Cardiovascular conditions in the spectrum of acute coronary syndromes are characterized by sex differences with regard to pathophysiology, risk factors, clinical presentation, invasive and pharmacologic treatment, and outcomes. This review delves into these differences, including specific subsets like myocardial infarction with non-obstructed coronary arteries or Spontaneous Coronary Artery Dissection
-
Letter to the Editor: Ross procedure: Valve function, clinical outcomes and predictors after 25 years’ follow-up Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-28 Burhanuddin Sohail Rangwala, Hussain Sohail Rangwala
The following letter presents a critique of the study titled "Ross procedure: valve function, clinical outcomes and predictors after 25 years’ follow-up," recently published in your esteemed journal. This study provides a comprehensive analysis of the long-term outcomes of the Ross procedure, focusing on survival rates and incidence of valve dysfunction over a 25-year period. Despite revealing excellent
-
Transcarotid versus trans-axillary/subclavian transcatheter aortic valve replacement (TAVR): A systematic review and meta-analysis Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-28 Sagun Dawadi M.B.B.S., Prakash Raj Oli M.B.B.S., Dhan Bahadur Shrestha M.D., Jurgen Shtembari M.D., Kailash Pant M.D., Bishesh Shrestha M.D., Jishanth Mattumpuram M.D., Daniel H. Katz M.D.
Transcatheter Aortic Valve Replacement (TAVR) is the treatment of choice in patients with severe aortic stenosis. Transcarotid (TCa) or Trans-axillary/subclavian (TAx/Sc) are safer and less invasive non-femoral approaches, where transfemoral access is difficult or impossible to obtain. This meta-analysis was performed based on PRISMA guidelines after registering in PROSPERO (CRD42023482842). This meta-analysis
-
Cardiovascular disease risk communication: Strategies, impact, and future directions Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-28 S, n, e, h, a, , A, n, n, i, e, , S, e, b, a, s, t, i, a, n, , M, D
Cardiovascular disease (CVD) prevails as the leading cause of global mortality, claiming the lives of an estimated 17.9 million individuals in 2019, representing a substantial portion of worldwide mortality. Research indicates that individuals with a deeper understanding of their cardiovascular health are more inclined to adhere to preventive measures, potentially leading to improved outcomes. Moreover
-
Kissing shockwave balloon in a case of extensive calcified abdominal aorta during transfemoral TAVI Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-28 Angela Buonpane M.D., Giancarlo Trimarchi M.D., Cataldo Palmieri M.D., Anees Ali Ahmed Al Jabri M.D., Sergio Berti M.D., Antonio Rizza M.D.
An 84-year-old man with extensive calcified atherosclerosis of the infrarenal abdominal aorta was diagnosed with severe aortic valve stenosis, presenting with dyspnea. To facilitate transfemoral approach during the TAVI procedure, IVUS-guided intravascular lithotripsy was successfully performed using Kissing Shockwave Balloon Technique.
-
Mechanical Cardiopulmonary Resuscitation Devices: Evidence Synthesis with an Umbrella Review Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-28 Angela Buonpane, Carlo De Innocentiis, Marco Bernardi, Marco Borgi, Luigi Spadafora, Carlo Gaudio, Francesco Burzotta, Carlo Trani, Giuseppe Biondi Zoccai
Sudden cardiac arrest is a significant cause of death worldwide. Good quality cardiopulmonary resuscitation increases patients’ survival. Manual cardiopulmonary resuscitation is often ineffective as rescuers may experience physical and mental fatigue. Mechanical cardiopulmonary resuscitation devices are designed to address this issue, providing an automated approach for high-quality resuscitation.
-
Chronic thromboembolic pulmonary hypertension and balloon pulmonary angioplasty – Where are we in 2024? Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-23 Sharif M. Kayali, Bernhard E. Dietz, Bilal S. Siddiq, Michael Ghaly, Timothy S. Owens, Rami N. Khouzam
Pulmonary endarterectomy (PEA) is the first-line treatment for patients with chronic thromboembolic pulmonary hypertension (CTEPH). However, some patients with CTEPH are considered inoperable, and in the last decade, balloon pulmonary angioplasty (BPA) has emerged as a viable therapeutic option for these patients with prohibitive surgical risk or recurrent pulmonary hypertension following PEA. Numerous
-
Health inequalities in cardiopulmonary resuscitation and use of automated electrical defibrillators in out-of-hospital cardiac arrest Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-23 Syeda Anum Zahra, Rozina Yasmin Choudhury, Rameez Naqvi, Adam J Boulton, C. Anwar A. Chahal, Sabrina Munir, Mafalda Carrington, Fabrizio Ricci, Mohammed Y Khanji
Out of hospital cardiac arrest (OHCA) outcomes can be improved by strengthened the chain of survival, namely prompt cardiopulmonary resuscitation (CPR) and automated external defibrillator (AED). However, provision of bystander CPR and AED use remains low due to individual patient factors ranging from lack of education to socioeconomic barriers and due to lack of resources such as limited availability
-
The role of ICDs in patients with sarcoidosis–A comprehensive review Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-23 Sebastian Mactaggart, Raheel Ahmed
Implantable cardioverter defibrillator (ICD) use in cardiac sarcoidosis (CS) to prevent sudden cardiac death (SCD) is a potentially life-saving intervention. However, the factors that determine outcome in this cohort remains largely unknown. This review analyses CS patients with an ICD and highlights determinants of poor outcome. Analysis of studies which used the 2014 HRS Consensus, 2017 AHA/ACC/HRS
-
The Roles of C-Reactive Protein-Albumin Ratio as A Novel Prognostic Biomarkers in Heart Failure Patients: A Systematic Review Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-22 Roy Bagus Kurniawan, Pratista Oktafia, Pandit Bagus Tri Saputra, Dinda Dwi Purwati, Mahendra Eko Saputra, Irma Maghfirah, Novia Nurul Faizah, Yudi Her Oktaviono, Firas Farisi Alkaff
C-Reactive Protein (CRP)-albumin ratio (CAR) is a novel prognostic biomarker that is predicted to be a more reliable indicator than CRP or albumin alone. Therefore, this systematic review aimed to evaluate the role of CAR value in predicting poor outcomes of heart failure (HF) patients. We conducted a literature search across ProQuest, PubMed, ScienceDirect, Web of Science, and Scopus. All related
-
Peripartum cardiomyopathy unveiled: Etiology, diagnosis, and therapeutic insights Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-22 Ardea Safira, Angela Kimberly Tjahjadi, Galih Januar Adytia, Alief Waitupu, Henry Sutanto
Peripartum cardiomyopathy (PPCM) remains a significant challenge in maternal health, marked by its unpredictable onset and varied clinical outcomes. With rising incidence rates globally, understanding PPCM is vital for improving maternal care and prognosis. This review aims to consolidate current knowledge on PPCM, highlighting recent advancements in its diagnosis, management, and therapeutic approaches
-
Frequent POCUS and auscultation for an earlier diagnosis of takotsubo syndrome and unraveling of its pathophysiology: The possible crucial role of LVOTO Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-22 John E. Madias
There is ample literature associating LVOTO with hypertension, AMI, LV hypertrophy, sigmoid septum, HCM, and TTS, particularly in midde aged/elderly/postmenopausal women, suggestive of a causal role for LVOTO in the pathophysiology of TTS. Although there is significant evidence that TTS is triggered by a sudden autonomic sympathetic nervous system surge and/or elevated blood-ridden catecholamines,
-
DEVELOPMENT OF THE CARDIOPROTECTIVE DRUGS CLASS BASED ON PATHOPHYSIOLOGY OF MYOCARDIAL INFARCTION: A COMPREHENSIVE REVIEW Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-21 EMANUEL TENÓRIO PAULINO
The cardiovascular system is mainly responsible for the transport of substances necessary to cellular metabolism. However, for the good performance of this function, there is need for adequate control of blood pressure levels of tissue perfusion and systemic arterial. Acute myocardial infarction is one of the complications of the cardiovascular system, that most affects the population around the world
-
Comment on "Mortality and Burden Related with aortic aneurysm and dissections. The importance of information and education." Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-21 Tazheen Saleh Muhammad, Muhammad Abdullah Naveed
-
Systematic literature review and critical analysis of RDW in patients with aortic pathologies Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-21 Giuseppe Lippi, Fabian Sanchis–Gomar, Camilla Mattiuzzi
Diseases of the aorta, such as aortic aneurysm, dissection, and rupture, account for a large proportion of acute clinical emergencies. The red blood cell distribution width (RDW), which directly reflects anisocytosis (i.e., the heterogeneity of erythrocyte volumes), has emerged as a promising biomarker for many cardiovascular pathologies. Thus, we aimed to explore the implication of RDW in aortic pathologies
-
Isolated Primary Cardiac Angiosarcoma Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-17 Endurance Evbayekha, Anupama K Rao, Jeremy Leidenfrost, Craig K Reiss
Cardiac angiosarcoma (CAS) is the most prevalent primary cardiac tumor, often affecting young males. We present a case of this rare entity in a young female, highlighting the multidisciplinary team's role and multimodality imaging in the diagnosis and management.
-
Animal models of Lyme carditis. Understanding how to study a complex disease Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-16 Samer Maher, Laura Scott, Shetuan Zhang, Adrian Baranchuk
Lyme carditis, a well-established manifestation of Lyme disease, has been studied in animal models to improve understanding of its pathogenesis. This review synthesizes existing literature on these models and associated disease mechanisms. Searches in MEDLINE, Embase, BIOSIS, and Web of Science yielded 53 articles (47 mice models and 6 other animal models). Key findings include: 1) Onset of carditis
-
Impact of angiotensin receptor-neprilysin inhibition (ARNI) in improving ejection fraction and left and right ventricular remodeling in heart failure Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-16 Sandeep Bhushan, Xin Huang, Fenglin Jiang, Zongwei Xiao
Angiotensin receptor neprilysin inhibitors (ARNI), a new therapeutic class of agents acting on the renin angiotensin aldosterone system (RAAS) and neutral endopeptidase system has been developed in treatment of ventricular remodeling and has attracted considerable attention. The first in class is LCZ696, which is a molecule that combines Valsartan (ARB) and Sacubitril (neprilysin inhibitor) within
-
PR prolongation as a predictor of atrial fibrillation onset: A state-of-the-art review Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-16 Zain S. Ali, Abdullah Bhuiyan, Purav Vyas, Andres F. Miranda-Arboleda, Gary Tse, George Bazoukis, Cengiz Burak, Wael Abuzeid, Sharen Lee, Shyla Gupta, Amin Meghdadi, Adrian Baranchuk
First-degree atrioventricular block (1-AVB), characterized by a PR interval exceeding 200 milliseconds, has traditionally been perceived as a benign cardiac condition. Recently, this perception has been challenged by investigations that indicate a potential association between PR prolongation and an elevated risk of atrial fibrillation (AF). To consolidate these findings, we performed a comprehensive
-
Comment on: Insights into Covid-19 Mortality: A Comprehensive Study of Cardiovascular Sensitivity, Gender, Race, and Geography Trends in the United States (2020-2023) Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-16 Azzam Ali, Mukesh Kumar, Muhammad Basit Azeem, Arwa Khan, Syed Ali Arsal
-
Topic: Precision Medicine Approaches in Cardiology: Personalized Therapies for Improved Patient Outcomes, a systematic review Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-16 Hyma Bamba, Gurmehar Singh, Jobby John, Pugazhendi Inban, Priyadarshi Prajjwal, Haitham Alhussain, Mohammed Dheyaa Marsool Marsool
Personalized medicine is a novel and rapidly evolving approach to clinical practice that involves making decisions about disease prediction, prevention, diagnosis, and treatment by utilizing modern technologies. The concepts of precision medicine have grown as a result of ongoing developments in genomic analysis, molecular diagnostics, and technology. These advancements have enabled a deeper understanding
-
It's a long way to the top! Congenital venous anomalies and left isomerism limiting atrial fibrillation transcatheter ablation Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-16 Carlo De Innocentiis, Angela Buonpane, Antonio Totaro, Gennaro Restaino, Pasquale Astore, Martina Guarino, Valerio Langella, Sabina Gallina, Matteo Santamaria
. Atrial fibrillation is the most common sustained cardiac arrhythmia in adults and it is associated with a high burden of mortality and morbidity worldwide. Catheter ablation is increasingly used to improve symptoms and prognosis in selected patients. Lower limb venous access with subsequent transseptal approach to the left atrium is the standard procedure for atrial fibrillation catheter ablation
-
Nano Revolution in Cardiovascular Health: Nanoparticles (NPs) as Tiny Titans for Diagnosis and Therapeutics Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-16 Junaid Abid, Fatma Mohamed Ameen Khalil, Sumbul Saeed, Shahid Ullah Khan, Imran Iqbal, Safir Ullah khan, Stefan Anthony
Cardiovascular diseases (CVDs) are known as life-threatening illnessescaused by severe abnormalities in the cardiovascular system. They are a leading cause of mortality and morbidity worldwide.Nanotechnology integrated substantialinnovations in cardiovascular diagnostic and therapeutic at the nanoscale. This in-depth analysis explores cutting-edge methods for diagnosing CVDs, including nanotechnological
-
Long-term outcomes and predictors of mortality in patients with pulmonary embolism undergoing catheter-directed thrombolysis: a 10-year retrospective study Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-16 Sushan Gupta, Tessabella Magliochetti Cammarata, Daniel Cheah, Nellie Haug, Talha-Bin Farooq, Vishesh Paul, Danish Thameem
Data regarding long-term outcomes of catheter-directed thrombolysis (CDT) post intermediate risk pulmonary embolism (PE), the choice of anticoagulation, and factors affecting mortality are not well studied. We conducted a ten-year retrospective observational chart review of patients undergoing CDT for intermediate-risk PE. Patients were followed for a period of 1 to a maximum of 5 years from the PE
-
Racial disparities among patients with cardiac sarcoidosis and arrhythmias in the United States: A propensity matched-analysis from the national inpatient sample database 2016-2020 Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-13 Raheel Ahmed, Haania Shahbaz, Kamleshun Ramphul, Sebastian Mactaggart, Mansimran Singh Dulay, Joseph Okafor, Alessia Azzu, Rajdeep Khattar, Athol Umfrey Wells, Kshama Wechalekar, Vasilis Kouranos, Anwar Chahal, Rakesh Sharma
Cardiac sarcoidosis (CS) is frequently associated with conduction abnormalities and arrhythmias. In this study, we aim to evaluate racial disparities in the frequency of arrhythmias, and associated co-morbidities, among patients with CS. White and African American (AA) patients diagnosed with CS were identified and compared from the 2016-2020 National Inpatient Sample (NIS) database whilst adjusting
-
Predicting stroke in Asian patients with atrial fibrillation using machine learning: A report from the KERALA-AF registry, with external validation in the APHRS-AF registry Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-11 Yang Chen, Ying Gue, Peter Calvert, Dhiraj Gupta, Garry McDowell, Jinbert Lordson Azariah, Narayanan Namboodiri, Tommaso Bucci, A. Jabir, Hung Fat Tse, Tze-Fan Chao, Gregory Y.H. Lip, Charantharayil Gopalan Bahuleyan
[Display omitted]
-
Safety and efficacy of antithrombotics in outpatients with symptomatic COVID-19: A systematic review and meta-analysis Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-11 Saad Ali Ansari, Nooraldin Merza, Madiha Salman, Adarsh Raja, Bushra Zafar Sayeed, Hafsah Alim Ur Rahman, Sunaina Bhimani, Afrah Saeed Shaikh, Unaiza Naqi, Areeba Farooqui, Simra Afridi, Ahsan Feroze, Ishaque Hameed
Coronavirus disease (COVID-19) is a global health emergency, with well over six hundred million infections and over six million deaths to date. Besides other ramifications, it is also associated with inflammation and an augmented risk of thromboembolic complications. Despite this, the risks and benefits of antithrombotic drugs in patients with mild to moderate COVID-19 have not been well-established
-
Trends towards increase of Cardiovascular diseases mortality in USA: A comparison with Europe and the importance of preventive care Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-11 Antonio V Sterpetti, Raimondo Gabriele, Immacolata Iannone, Monica Campagnol, Valeria Borrelli, Paolo Sapienza, Luca Dimarzo
The aim of our study was to analyze exposure of the general population to established risk factors for cardiovascular disease (CVD), which might have determined the trend towards increased mortality rates related with CVD from 2015 to 2019 in USA. We analyzed epidemiological of data from the US National Health and Nutrition Examination Survey and from the European Health Interview Survey to determine
-
Back to the basics: The need for an etiological classification of chronic heart failure Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-10 Filippos Triposkiadis, Andrew Xanthopoulos, Stavros G. Drakos, Konstantinos Dean Boudoulas, Alexandros Briasoulis, John Skoularigis, Konstantinos Tsioufis, Harisios Boudoulas, Randall C. Starling
The left ventricular (LV) ejection fraction (LVEF), despite its severe limitations, has had an epicentral role in heart failure (HF) classification, management, and risk stratification for decades. The major argument favoring the LVEF based HF classification has been that it defines groups of patients in which treatment is effective. However, this reasoning has recently collapsed, since medical treatment
-
Mortality patterns in older adults with infective endocarditis in the US: A retrospective analysis Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-10 Hamza Ashraf, Zain Ali Nadeem, Haider Ashfaq, Sophia Ahmed, Ali Ashraf, Abdulqadir J. Nashwan
[Display omitted]
-
Letter to the editor: Cardiovascular risk prediction with cardio-ankle vascular index in the Malaysian cohort study Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-10 Atta Ul Haq Burki, Ahmed Ali Khan, Danish Ali Ashraf, Asjad Rizvi, Saad Hassan
-
Relationship between donor ejection fraction, left ventricular wall thickness and mortality in heart transplants recipients Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-10 Cesar Rodrigo Zoni, Matthew Dean, Laurel A. Copeland, Julia R Silverman, Christopher Lemoine, Aviral Mahajan, Eduardo R. Perna, Yazhini Ravi, Chittoor B. Sai Sudhakar
This study explored the impact of donor left ventricular ejection fraction (EF) and left ventricular wall thickness (LVWT) on mortality among heart transplant (HTx) recipients.
-
A review regarding the article ‘clinical and echocardiographic outcomes of patients undergoing transcatheter edge-to-edge repair for functional vs degenerative mitral valve regurgitation’ Curr. Prob. Cardiology (IF 4.2) Pub Date : 2024-02-10 Zhen Li, Fenglin Yi, Kangxi Zuo, Gang Zhao, Sandeep Bhushan
Echocardiography is widely available in most cardiac centers, plays a key role in both the diagnosis and management of IE, is often the first-hand imaging modality, and should be performed immediately when mitral regurgitation is suspected. In addition, it is helpful during therapy and after surgery to assess valve morphology and function, complications, and heart function. In particular, transthoracic
-